Olsen SN, Anderson B, Hatton C, Chu Z, Simpkins C, Wen Y, Bourgeois W, Haarer EL, Brown M, Jeselsohn R, Welm AL, Toska E,, 2025, Armstrong SA. Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer, Cell Rep Med., 102192. doi: 10.1016/j.xcrm.2025.102192. PMID: 40516531 PubMed
Blawski R, Vokshi BH, Guo X, Kittane S, Sallaku M, Chen W, Gjyzari M, Cheung T, Zhang Y, Simpkins C, Zhou W, Kulick A, Zhao P, Wei M, Shivashankar P, Prioleau T, Razavi P, Koche R, Rebecca VW, de Stanchina E, Castel P, Chan HM, Scaltriti M, Cocco E, Ji H, Luo M, Toska E., 2024, Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer, Cell Rep., 43(5):114174. doi: 10.1016/j.celrep.2024.114174. PMID: 38700982 PubMed
